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Background/aim: The prognostic value of the red cell distribution width (RDW) as a cost-effective and noninvasive test in acute
pulmonary embolism (PE) is still unknown. We aimed to investigate the prognostic value of the admission RDW level in the long-term
survival of PE patients.
Materials and methods: In this registry-based, prospective cohort study, a total of 378 patients (mean age: 60.4 ± 17.11 years, 47.4%
female) who presented with acute PE were enrolled. All the clinical data for each patient were obtained from our institutional PE
registry. The follow-up was performed at a median time of 17 months. The primary endpoint was death at follow-up.
Results: The mean RDW in study patients was 14.67 ± 2.13. The all-cause mortality rate during the follow-up was 15.6% (n = 59). After
adjustment for potential confounders, the relationship between RDW and long-term mortality showed a trend of a significant level
(hazard ratio: 1.109; 95% CI, 0.998−1.232; P = 0.053). We divided patients into 3 groups based on the European Society of Cardiology’s
classification. As we moved from the low risk to the higher risk categories, the mean RDW increased significantly (P = 0.037).
Conclusion: It seems there may be an independent association between RDW at presentation and PE mortality within 17 months.
Key words: Pulmonary embolism, red cell distribution width, mortality

1. Introduction
Acute pulmonary embolism (PE) is a common lifethreatening cardiovascular disease with 15%–20%
mortality (1). Complete blood count is a part of routine
laboratory tests performed for patients admitted to
the emergency department, and red cell distribution
width (RDW), as a marker of anisocytosis, reflects the
heterogeneity of red blood cell (RBC) size. Recent studies
have shown that RDW is associated with the prognosis of
many cardiovascular conditions (2). To our knowledge,
only a few studies have shown that RDW is not only
associated with the risk of PE but is also a predictor of early
mortality in acute PE (3-5). However, the prognostic value
of RDW as a cost-effective and noninvasive test in acute
PE, specifically in the long term, is still unknown. The
present study sought to investigate the prognostic value of
the admission RDW level in the long-term survival of PE
patients.
* Correspondence: jenab@razi.tums.ac.ir
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2. Materials and methods
2.1. Population and study protocol
This is a registry-based, prospective cohort study
conducted in a tertiary cardiac center. In total, 378
confirmed acute PE patients were enrolled in the study.
Individuals with a previous PE history and end-stage renal
disease were excluded. The diagnosis of PE was confirmed
either by pulmonary computed tomography angiography
or by ventilation-perfusion lung scan. The treatment
consisted of heparin or low-molecular-weight heparin in
the acute phase. Decision about the need for thrombolytic
therapy was made by the physician based on the clinical
condition of the patients. Hence, the patients were placed
on warfarin at the time of discharge.
The patients, once admitted to the hospital with a
diagnosis of PE, were followed up after discharge until
death either by outpatient clinic visits or by telephone
contacts in 6-month intervals. The median follow-up time
available in the registry at the time of this study was 17
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months. All patients admitted to the hospital were asked
whether they would give consent for the use of their
medical data for research purposes, and they completed
the informed consent form. The study design was approved
by the hospital ethics committee of the institutional review
board.
The simplified Pulmonary Embolism Severity Index
(sPESI) was calculated by allocating a score of 1 to any
of the following characteristics: age > 80 years, history of
cancer, chronic cardiopulmonary disease, heart rate ≥ 110
beats per minute, systolic blood pressure < 100 mm Hg,
and arterial oxygen saturation < 90%. A score of ≥1 was
considered high.
Study patients were divided into 3 risk groups
according to the guidelines of the European Society of
Cardiology (ESC) on the diagnosis and management of
acute PE (6). According to the ESC guidelines, patients are
categorized in 4 groups: 1- low risk, 2- intermediate-low,
3- intermediate-high, and 4- high risk, based on the risk of
early (in-hospital or 30-day) outcome. In the present study,
because there were only 2 patients in the high risk category,
we added them to the intermediate-high risk category
and categorized patients into 3 risk groups: 1- low risk, 2intermediate-low, 3- intermediate-high/high risk patients.
This classification was based on 4 risk parameters: shock
or hypotension, sPESI ≥ 1, right ventricular dysfunction in
imaging, and cardiac biomarkers of myocardial injury or
dysfunction. Right ventricular dysfunction was considered
to exist if it was present on echocardiography or computed
tomography angiography.
Either high-sensitivity troponin T of ≥14 pg/mL or
N-terminal pro-BNP of >600 pg/mL was regarded as a
positive cardiac biomarker. Red cell indices were analyzed
using K3-EDTA as an anticoagulant in a LavenderTop Tube. RDW-SD was calculated as the width of the
erythrocyte distribution curve at a relative height of 20%
above the baseline. According to our automated coulter
(SYSMEX KX-21N Hematology Analyzer), the lower and
upper limits of the normal laboratory reference range were
11.6% and 14.6%, respectively.
2.2. Statistical analysis
The continuous variables were described through
means and standard deviations (SDs) when the data
were normally distributed, or medians with 25th and
75th percentiles whenever the data were not normally
distributed. The normal distribution of the data was
assessed through the aforementioned descriptive
measures as well as histogram charts. The continuous
variables were compared among the ESC risk classification
groups using one-way analysis of variance (ANOVA) or
the Kruskal–Wallis test. The categorical variables were
presented with frequencies and percentages and were
compared between the abovementioned groups applying

the chi-square or Fisher exact test, as appropriate. Survival
curves were calculated using the Kaplan–Meier method
and were compared between the first RDW categories
applying the log-rank test. The Cox proportional hazards
(PH) model was applied to evaluate the univariate effect
of the variables, as well as unadjusted and adjusted effects
of first RDW, on the long-term mortality, and the effects
were reported through the hazards ratio (HR) with 95%
confidence intervals (CIs). Those variables that were
associated with long-term mortality with P-value less
than 0.1 were considered as potential confounders. PH
assumption was assessed through the chi-square test of
the correlation coefficient between the scaled Schoenfeld
residuals and the transformed survival times (P = 0.121).
The method proposed by Heagerty et al. (7) was applied to
find a best cut-off for the first RDW predicting long-term
mortality at the median follow-up time.
IBM SPSS 23.0 for Windows (IBM Corp., Armonk,
NY, USA), Stata release 13 (StataCorp LP, College Station,
TX, USA), and the “survivalROC” package in R software
(R Foundation for Statistical Computing, Vienna, Austria)
were used to conduct the statistical analyses (8,9).
3. Results
The mean age of the study population was 60.4 ± 17.11
years. The study patients consisted of 179 (47.4%) females
and 199 (52.6%) males. The most common symptom on
admission was dyspnea. Overall, 59.3% of the patients
had a high sPESI score and 73% had a positive cardiac
biomarker. Additionally, RV dysfunction was detected in
71.4% of the patients. The mean RDW in study patients
was 14.67 ± 2.13. The median follow-up duration was 17
months (95% CI: 15.4-18.5) and the all-cause mortality
rate in this period was 15.6% (n = 59).
The comparison of baseline characteristics between
the dead and surviving patients is depicted in Table 1.
Patients in the deceased group were more likely female
and older than those in the surviving group. The deceased
group also had significantly more history of malignancy,
oxygen saturation < 90%, sPESI score ≥ 1, atrial fibrillation
rhythm, positive cardiac biomarkers, and higher mean
RDW [1.194 (95% CI: 1.101-1.296)] and white blood cell
count.
In the next step, the relationship between mean
RDW and long-term mortality was adjusted for other
confounding factors and the results are outlined in Table
2. According to Table 2, the adjusted hazard ratio for the
relationship between RDW and long-term mortality was
1.109 (95% CI: 0.998-1.232). The independent association
between RDW and mortality tended to be significant (P
= 0.053).
In further analysis we performed a comparison between
the 3 risk groups defined based on the ESC classification:
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Table 1. Univariate effect of variables on long-term mortality in study patients.
Survived

Died

HR

CI (95%)

P-value

Female

143 (44.8)

36 (61)

1.786

1.057-3.019

0.030

Age

58.81 ± 17.1

69.25 ± 14.35

1.038

1.019-1.058

<0.001

Dyspnea

279 (88)

51 (86.4)

0.966

0.455-2.053

0.929

Syncope

34 (12.3)

3 (5.4)

0.509

0.159-1.634

0.257

Chest pain

130 (48.1)

24 (43.6)

0.853

0.498-1.461

0.562

Heart rate ≥ 110 bpm

66 (34.6)

15 (35.7)

1.310

0.769-2.234

0.321

Systolic blood pressure < 100 mmHg

13 (4.1)

3 (5.1)

0.978

0.291-3.285

0.972

Respiratory rate

24.07 ± 6.3

25.12 ± 8.76

1.028

0.988-1.070

0.169

O2Sat < 90%

55 (17.3)

17 (28.8)

2.122

1.201-3.748

0.010

sPESI ≥ 1

176 (55.2)

48 (81.4)

3.547

1.833-6.864

<0.001

Diabetes mellitus

55 (17.2)

13 (22)

1.292

0.697-2.393

0.417

Hypertension

124 (38.9)

26 (44.1)

1.241

0.742-2.076

0.411

Smoking

68 (21.3)

9 (15.3)

0.731

0.358-1.490

0.389

Chronic pulmonary disease

11 (3.4)

1 (1.7)

0.533

0.074-3.853

0.533

Immobility ≥ 3 days

82 (25.7)

22 (37.3)

1.423

0.834-2.425

0.195

Surgery within previous 4 weeks

45 (14.1)

7 (11.9)

0.705

0.317-1.567

0.391

Malignancy

11 (3.4)

8 (13.6)

2.871

1.325-6.219

0.007

Complete RBBB

20 (6.3)

6 (10.3)

1.345

0.566-3.197

0.502

S1Q3T3

97 (30.7)

18 (30.5)

1.104

0.633-1.928

0.727

T inversion in precordial leads

104 (32.9)

24 (41.4)

1.516

0.897-2.564

0.121

Atrial fibrillation

12 (3.8)

7 (12.1)

2.555

1.017-6.417

0.046

Positive cardiac biomarkers

224 (74.2)

52 (92.9)

4.509

1.625-12.512

0.004

Right ventricular dysfunction

227 (71.2)

43 (72.9)

1.393

0.761-2.550

0.283

RDW (%)

14.44 ± 1.87

15.95 ± 2.93

1.194

1.101-1.296

<0.001

WBC (per 103 increase)

10,690 ± 3552

11,509 ± 3888

1.070

1.010-1.130

0.032

Hemoglobin (g/dL)

13.74 ± 2.29

13.59 ± 2.31

0.980

0.875-1.099

0.734

Mean corpuscular volume (fL)

85.56 ± 7.67

85.05 ± 7.21

0.993

0.961-1.026

0.658

Platelet count (number)

22,4083 ± 91,850

21,5261 ± 77,566

0.999

0.996-1.002

0.514

Electrocardiographic findings

Complete blood count findings

Categorical variables are presented as numbers (percent), and continuous variables are presented as mean ± standard deviation. sPESI,
Simplified Pulmonary Embolism Severity Index; RBBB, right bundle branch block; RDW, red cell distribution width; WBC, white
blood cells.

320

KHEIRKHAH-SABETGHADAM et al. / Turk J Med Sci
Table 2. Unadjusted and adjusted association between RDW and long-term mortality of patients with
pulmonary embolism.
HR

95.0% CI

P

1.194

1.101

1.296

<0.001

1.108

0.999

1.229

0.053

Unadjusted
RDW
Adjusted
RDW
Sex

1.805

1.027

3.173

0.040

Age

1.026

1.005

1.048

0.016

O2Sat < 90

1.254

0.668

2.353

0.481

sPESI ≥ 1

2.152

0.931

4.971

0.073

Malignancy

1.313

0.490

3.516

0.588

Atrial fibrillation

1.377

0.586

3.238

0.463

Positive cardiac biomarkers

2.309

0.790

6.753

0.126

WBC (per 10 increase)

1.000

1.000

1.000

0.247

3

Proportional hazard assumption; P = 0.121.
RDW, Red cell distribution width; sPESI, Simplified Pulmonary Embolism Severity Index; WBC, white
blood cells.

low, low-intermediate, and high-intermediate + high.
Mortality was 3% in the low risk, 12.4% in the intermediate,
and 21.9% in the high risk patients (P < 0.001). As we
moved from low risk towards the higher risk categories,
the mean RDW increased significantly (P = 0.037; Table
3). Similar trends of increase from low to high risk groups
were also significant in the mean age and white blood cell
count (Table 3).
4. Discussion
Based on the results of our study, it seems there may be
an independent association between RDW at presentation

and PE mortality within 17 months. To our knowledge,
the present study is one of the first of its kind to evaluate
the association between RDW and long-term mortality of
patients with acute PE.
Previous studies reported the prognostic value of
RDW at admission in the short-term follow-up of patients
with PE. Zorlu et al. (5) concluded that high RDW was
associated with worse short-term outcome and suggested
that RDW seems to aid in risk stratification of patients
with acute PE. Ozsu et al. (3) studied 702 acute PE patients
and concluded that high RDW level was an independent
predictor of short-term mortality. In the study by Sen

Table 3. Comparison of baseline characteristics and blood count indices in different risk groups based on the European Society of
Cardiology risk classification.
Low risk
n = 33

Low-intermediate risk
n = 185

High-intermediate plus high risk
n = 160

P-value

47.6 ± 13.65

58.9 ± 16.60

64.8 ± 16.78

<0.001

RDW (percent)

14.14 ± 1.96

14.50 ± 2.06

14.98 ± 2.21

0.037

WBC (n/mm3)

9770 ± 2846

10,470 ± 3123

11,437 ± 4157

0.010

Hb (g/dL)

12.98 ± 2.54

13.94 ± 2.17

13.59 ± 2.34

0.062

Platelets (n/mm3)

256,000
(181,700, 298,000)

204,500
(160,550, 277,750)

198,500
(160,250, 259,750)

0.112

Age
†

WBC: White blood cells; Hb: hemoglobin; RDW: red cell distribution width.
Data are presented as mean ± standard deviation or median (25th, 75th percentile).
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et al. (4), among 208 patients with acute PE, RDW was
associated with a 4.08-fold increase in PE mortality in
the first 100 days. In the present study we investigated
the relationship between RDW and long-term mortality
in such patients and observed that after adjustment for
other factors there was a trend of a significant association
between RDW at admission and long-term mortality after
a mean follow-up of 17 months (P = 0.053). The reason for
not reaching a significant level may be the small number of
deceased patients. Further studies including larger sample
sizes are needed to confirm the results.
We also classified our PE patients into 3 risk groups
according to the ESC guidelines. We observed that in
addition to white blood cell count, RDW increased
significantly as the risk of worse outcome increased. The
significant correlation of RDW with the ESC risk groups
suggests that increased RDW not only foresees long-term
mortality but also might augment the efficiency of the
baseline risk assessment of patients with confirmed PE at
admission.
The pathophysiology of anisocytosis and elevated
RDW levels in PE is still a matter of debate. Some
evidence shows that RDW acts quite similar to wellknown inflammatory markers such as leukocytosis and
elevated C-reactive protein (10). Nonetheless, this seems
to be an oversimplification of the role of RDW. Others
have hypothesized that RDW is associated with increased
prothrombotic effects of RBCs and even some genetic
factors (11). Some recent studies showed that RDW
increases in many acute conditions related to decreased
oxygen saturation and hypoxemia, including acute
hemorrhage, pneumonia, pneumothorax, and atelectasis
(12). Hypoxia could augment bone marrow erythropoiesis
by upregulating erythropoietin production by the kidneys,
which in turn results in the release of variably sized RBCs
into the circulation (12). The correlation between higher
RDW and higher long-term PE mortality may reflect its
direct association with the severity of PE. Patients with
more severe PE experience lower oxygen saturation and

poorer hemodynamics. This condition produces much
more inflammatory cytokines and oxidative stress. Also,
the activation of sympathetic and other neurohormonal
mediators such as angiotensin II is more prevalent in
severe PE. All of these mechanisms may affect the RBC
formation process, which might provide some explanation
for the increased RDW in high risk PE patients.
There are some limitations in the present study
that need to be addressed. Although in our study RDW
was shown to be independent of other factors, such
as hemoglobin levels and malignancy, some probable
confounders, such as iron deficiency anemia, recent
treatment by iron supplements, and megaloblastic anemia,
might have inadvertently affected the results; however,
being an acute disease process, it seems improbable for PE
mortality to be directly affected by the hemoglobin level. In
addition, the PE-related inflammatory state may confound
the relationship between RDW and long-term mortality
(10). Further studies designed to control for these factors
from the beginning of the patient selection process are
suggested for a more robust confirmation of the observed
association between RDW and long-term PE mortality.
Additionally, the confirmation of the present association
needs further assessment with a larger study group. On
the other hand, this study benefits from the advantage
of introducing a novel association between RDW and
long-term PE mortality. Being a readily available and
low-cost technique, the calculation of RDW might be an
interesting test to help physicians stratify the risk category
of PE patients in the emergency room and guide treatment
selection of ambiguous cases.
In conclusion, in the current study, we observed
evidence showing possible independent association
between RDW at admission and long-term mortality
in PE patients; however, further studies are necessary to
confirm whether this simple, inexpensive test can be used
by physicians for risk stratification in patients with acute
PE.
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